Prescribing and Deprescribing for Heart Failure

Optimizing heart failure therapies, including the newer angiotensin-receptor neprilysin inhibitors (ARNIs), is critically important for older residents who have symptomatic heart failure with reduced ejection fraction (HFrEF), said Meenakshi Patel, MD, FACP, CMD, at the Annual Conference of AMDA – The Society for Post-Acute and Long-Term Care Medicine.